← Back to headlines
Stock Analysis: Biopharmaceutical Play Incyte Poised for Breakout
Shares of biopharmaceutical company Incyte are showing signs of a breakout, moving out of a seven-month trading range, according to analyst Carter Worth.
26 Jun, 18:18 — 26 Jun, 18:18
Sources
Showing 1 of 1 sources
Related Stories
Dyson Launches AI-Powered Smart Toothbrush With Internal Camera
22m ago
Apple Appoints John Ternus as New CEO Following Tim Cook’s Transition
25m ago
Chevron Announces $7 Billion Investment to Expand Venezuelan Oil Production
26m ago
US and Iran Engage in Major Military Exchange After Wedding Strike
28m ago